-
Listing
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLer maisTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLer maisEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLer maisEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Ler maisThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLer maisThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Ler maisShaping capital markets for future generations
Lymph&Co Hollandse 100
04/03/2016
Lymph&Co sounds gong for De Hollandse 100
On Sunday March 6 2016 is the second edition of De Hollandse 100. A winter duathlon with two sports the Dutch grew up with: skating and cycling. For this occasion a delegation of organizer Lymph & Co. opens trading at Beursplein 5.
The Lymph & Co fund is a fund that supports research to improve the treatment of lymphoma. Lymph & Co believes in innovation as a solution to the current challenges in the field of health. The key to this is excellence: the best ideas from the best researchers provide the best solutions for people and society.
For more information: www.dehollandse100.nl